Share Market: Another scary statement by Donald Trump, tremendous action will be seen in these stocks today

Donald Trump News Impact: The latest action of the US President has once again started a stir in the markets around the world. Its effect is being seen in the US futures and Asian markets. But, in the meantime, after his latest statement, there will be a big focus on a particular sector in the Indian stock market today. Tremendous action can be seen in these.

Actually, the US President can announce tariffs on the pharma sector. After this, the focus will be on Indian pharma companies today. Pharma companies like Sun Pharma, Lupin, Dr. Reddy's Laboratories, Aurobindo Pharma, Gland Pharma can see tremendous action today.

What did Donald Trump say now? Speaking at the Republican NRCC event, Trump said that big tariffs will soon be imposed on pharmaceuticals. Donald Trump said last week that tariffs on pharmaceuticals will come at a level you have not seen before. We are looking at pharmaceuticals as a separate category. We will announce it in the near future, and that is not far away. It is currently being reviewed. After this statement of Trump, Indian pharma stocks fell sharply. What will happen if tariffs on pharma are increased? Global brokerage firm Citi believes that pharma companies will try to pass on the burden of tariff hike to customers. If the cost is not ultimately passed on to patients, the entire supply chain will have to partially bear this increase. The brokerage also believes that a full pass-through of tariffs is difficult. Currently, India imposes a 10% tariff on US pharma imports, while the US does not impose any tariff on pharma imports from India. If 50% of the burden is passed on to customers, Citi estimates that the one-time EBITDA impact for these pharmaceutical companies could range from 1% to 7%.

Read More: Stocks to Buy For Long Term: These 11 stocks can see an increase of up to 25%